Autolus Therapeutics plc American Depositary Share
Symbol: AUTL (NASDAQ)
1.55
▲ (3.00%) 0.045
Company Description:
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Key Stats
- Today's Open: $1.52
- Today's High: $1.605
- Today's Low: $1.512
- Today's Volume: 292.74K
- Yesterday Close: $1.5
- Yesterday High: $1.57
- Yesterday Low: $1.5
- Yesterday Volume: 1.36M
- Last Min Volume: 6.18K
- Last Min High: $1.545
- Last Min Low: $1.545
- Last Min VWAP: $1.545
Company Profile
- Name: Autolus Therapeutics plc American Depositary Share
- Website: https://www.autolus.com
- Listed Date: 2018-06-22
- Location: LONDON, X0
- Market Status: Active
- CIK Number: 0001730463
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $433.81M
- Round Lot: 100
- Outstanding Shares: 266.14M
- Asset Type: ADRC
RECENT FILINGS FOR AUTL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-06 | SCHEDULE 13G/A | View |
| 2025-08-12 | 424B3 | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-06-30 | 424B3 | View |
| 2025-06-27 | 8-K | View |
| 2025-06-25 | SCHEDULE 13G | View |
| 2025-06-02 | 8-K | View |
| 2025-05-30 | 424B3 | View |
| 2025-05-30 | 8-K | View |
| 2025-05-15 | EFFECT | View |
| 2025-05-15 | 424B3 | View |
| 2025-05-13 | CORRESP | View |
| 2025-05-12 | UPLOAD | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
| 2025-05-08 | S-1 | View |
| 2025-05-08 | 10-Q | View |
| 2025-05-08 | 8-K | View |
| 2025-05-07 | SCHEDULE 13G/A | View |
| 2025-04-23 | 8-K | View |
Latest News on AUTL